Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 2
1956 1
1958 2
1963 2
1965 2
1967 2
1968 1
1969 4
1970 4
1971 6
1972 2
1973 1
1975 3
1976 5
1977 2
1978 2
1980 1
1981 5
1982 3
1983 2
1984 2
1985 3
1986 3
1987 6
1988 13
1989 14
1990 9
1991 7
1992 8
1993 7
1994 3
1995 15
1996 22
1997 15
1998 20
1999 12
2000 9
2001 12
2002 5
2003 5
2004 6
2005 10
2006 19
2007 16
2008 22
2009 30
2010 32
2011 52
2012 76
2013 75
2014 65
2015 76
2016 81
2017 77
2018 105
2019 108
2020 150
2021 187
2022 146
Text availability
Article attribute
Article type
Publication date

Search Results

1,429 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial.
Kristensen LE, Keiserman M, Papp K, McCasland L, White D, Lu W, Wang Z, Soliman AM, Eldred A, Barcomb L, Behrens F. Kristensen LE, et al. Among authors: soliman am. Ann Rheum Dis. 2022 Feb;81(2):225-231. doi: 10.1136/annrheumdis-2021-221019. Epub 2021 Dec 15. Ann Rheum Dis. 2022. PMID: 34911706 Free PMC article. Clinical Trial.
Impact of Endometriosis on Life-Course Potential: A Narrative Review.
Missmer SA, Tu FF, Agarwal SK, Chapron C, Soliman AM, Chiuve S, Eichner S, Flores-Caldera I, Horne AW, Kimball AB, Laufer MR, Leyland N, Singh SS, Taylor HS, As-Sanie S. Missmer SA, et al. Among authors: soliman am. Int J Gen Med. 2021 Jan 7;14:9-25. doi: 10.2147/IJGM.S261139. eCollection 2021. Int J Gen Med. 2021. PMID: 33442286 Free PMC article. Review.
Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.
Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Zeng J, Rubant S, Sinvhal R, Zhao Y, Soliman AM, Alperovich G, Leonardi C. Papp KA, et al. Among authors: soliman am. Br J Dermatol. 2021 Dec;185(6):1135-1145. doi: 10.1111/bjd.20595. Epub 2021 Sep 21. Br J Dermatol. 2021. PMID: 34157132 Free PMC article. Clinical Trial.
Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
Schlaff WD, Ackerman RT, Al-Hendy A, Archer DF, Barnhart KT, Bradley LD, Carr BR, Feinberg EC, Hurtado SM, Kim J, Liu R, Mabey RG Jr, Owens CD, Poindexter A, Puscheck EE, Rodriguez-Ginorio H, Simon JA, Soliman AM, Stewart EA, Watts NB, Muneyyirci-Delale O. Schlaff WD, et al. Among authors: soliman am. N Engl J Med. 2020 Jan 23;382(4):328-340. doi: 10.1056/NEJMoa1904351. N Engl J Med. 2020. PMID: 31971678 Clinical Trial.
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial.
Östör A, Van den Bosch F, Papp K, Asnal C, Blanco R, Aelion J, Alperovich G, Lu W, Wang Z, Soliman AM, Eldred A, Barcomb L, Kivitz A. Östör A, et al. Among authors: soliman am. Ann Rheum Dis. 2022 Mar;81(3):351-358. doi: 10.1136/annrheumdis-2021-221048. Epub 2021 Nov 23. Ann Rheum Dis. 2022. PMID: 34815219 Free PMC article. Clinical Trial.
Manifestations of HbSE sickle cell disease: a systematic review.
Khamees I, Ata F, Choudry H, Soliman AT, De Sanctis V, Yassin MA. Khamees I, et al. Among authors: soliman at. J Transl Med. 2021 Jun 16;19(1):262. doi: 10.1186/s12967-021-02931-1. J Transl Med. 2021. PMID: 34134694 Free PMC article. Review.
Global Cancer Education.
Soliman AS, Chamberlain RM. Soliman AS, et al. J Cancer Educ. 2021 Jul;36(Suppl 1):1-2. doi: 10.1007/s13187-021-02045-8. Epub 2021 Jun 12. J Cancer Educ. 2021. PMID: 34120327 No abstract available.
Impact of stress and hypertension on the cerebrovasculature.
Elsaid N, Saied A, Kandil H, Soliman A, Taher F, Hadi M, Giridharan G, Jennings R, Casanova M, Keynton R, El-Baz A. Elsaid N, et al. Among authors: soliman a. Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1643-1652. doi: 10.52586/5057. Front Biosci (Landmark Ed). 2021. PMID: 34994178 Free article. Review.
Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis.
Gelbard A, Anderson C, Berry LD, Amin MR, Benninger MS, Blumin JH, Bock JM, Bryson PC, Castellanos PF, Chen SC, Clary MS, Cohen SM, Crawley BK, Dailey SH, Daniero JJ, de Alarcon A, Donovan DT, Edell ES, Ekbom DC, Fernandes-Taylor S, Fink DS, Franco RA, Garrett CG, Guardiani EA, Hillel AT, Hoffman HT, Hogikyan ND, Howell RJ, Huang LC, Hussain LK, Johns MM 3rd, Kasperbauer JL, Khosla SM, Kinnard C, Kupfer RA, Langerman AJ, Lentz RJ, Lorenz RR, Lott DG, Lowery AS, Makani SS, Maldonado F, Mannion K, Matrka L, McWhorter AJ, Merati AL, Mori MC, Netterville JL, O'Dell K, Ongkasuwan J, Postma GN, Reder LS, Rohde SL, Richardson BE, Rickman OB, Rosen CA, Rutter MJ, Sandhu GS, Schindler JS, Schneider GT, Shah RN, Sikora AG, Sinard RJ, Smith ME, Smith LJ, Soliman AMS, Sveinsdóttir S, Van Daele DJ, Veivers D, Verma SP, Weinberger PM, Weissbrod PA, Wootten CT, Shyr Y, Francis DO. Gelbard A, et al. Among authors: soliman ams. JAMA Otolaryngol Head Neck Surg. 2020 Jan 1;146(1):20-29. doi: 10.1001/jamaoto.2019.3022. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 31670805 Free PMC article.
1,429 results